(Q46569182)

23 December 2017

title

Alemtuzumab (Campath-1H) and tacrolimus monotherapy after renal transplantation: results of a prospective randomized trial (English)

1 reference

23 December 2017

author name string

R Margreiter

1

1 reference

23 December 2017

J Klempnauer

2

1 reference

23 December 2017

P Neuhaus

3

1 reference

23 December 2017

F Muehlbacher

4

1 reference

23 December 2017

C Boesmueller

5

1 reference

23 December 2017

R Y Calne

6

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 July 2008

1 reference

23 December 2017

American Journal of Transplantation

published in

1 reference

23 December 2017

volume

8

1 reference

23 December 2017

issue

7

1 reference

23 December 2017

page(s)

1480-1485

1 reference

23 December 2017

Transplant tolerance in non-human primates: progress, current challenges and unmet needs

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02273.X

Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02273.X

Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02273.X

Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02273.X

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02273.X

Randomized trial of Alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02273.X

Reduced exposure to calcineurin inhibitors in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02273.X

Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02273.X

Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02273.X

The Banff 97 working classification of renal allograft pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02273.X

10.1111/J.1600-6143.2008.02273.X

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

18510632

1 reference

23 December 2017